Xilio Therapeutics Inc. (XLO)
Drugs • Health Care
Percentage
Change
| Mar 22 | Mar 23 | Apr 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|
Net Income to Common | -58 | -35 | |||
Net Income | -58 | -35 | |||
Profit | -58 | -35 | |||
Net Income Continuing | -58 | -35 | |||
Pretax Income | -58 | -35 | |||
Total Non-operating Income | 2 | 7 | |||
Operating Income | -61 | -42 | |||
Total Revenue | 6 | 44 | |||
Total Costs and Expenses | -67 | -86 | |||
Operating Expenses | -67 | -86 | |||
Research and Development Expenses | -41 | -56 | |||
Restructuring Charge | -1 | 0 | |||
Selling, General & Administrative Expenses | -25 | -30 |